Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one

US6458796B1 · kind B1 · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Helmut Haning · Milford, US
• Ulrich Niewohner · Wermelskirchen, DE
• Ulrich Rosentreter · Binnen, DE
• Thomas Schenke · Odenthal, DE
• Erwin Bischoff · Wuppertal, DE
• Karl-Heinz Schlemmer · Wuppertal, DE

Key dates

• Filing date: Feb 26, 2001
• Grant date: Oct 1, 2002
• Expiry date: Feb 26, 2021

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P15/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to novel dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one, to processes for their preparation and to their use as medicaments, in particular as inhibitors of cGMP-metabolizing phosphodiesterases.